{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-021882","form_type":"8-K","ticker":"RGBP","cik":"0001589150","company_name":"Regen BioPharma Inc","filed_at":"2025-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.443144+00:00","generated_at":"2026-05-17T21:50:12.292622+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Regen Biopharma enters $130K convertible note financing with CFI Capital","bullets":["Issued a 6% convertible promissory note for $130,000 principal; $13,000 original issue discount, net proceeds $117,000.","Note matures July 28, 2026; interest payable in common stock at holder's option.","Conversion price set at 60% of lowest trading price over prior 20 trading days on OTC Markets.","Company reserved 15,700,485 common shares for conversion; holder must maintain 5x coverage reserve."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-021882","json":"https://secwatch.observer/filing/0001641172-25-021882.json","markdown":"https://secwatch.observer/filing/0001641172-25-021882.md","text":"https://secwatch.observer/filing/0001641172-25-021882.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1589150/000164117225021882/0001641172-25-021882-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1589150/000164117225021882/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T21:50:12.292622+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}